Aurora-A interacts with AP-2α and down regulates its transcription activity

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Zou, Lihui ^a   Sun, Yimin ^b   Wang, Mingrong ^a   Zhan, Qimin ^a  

^a CANCER HOSPITAL   (China)

^b CapitalBio Corporation   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AURORA A KINASE; COMPLEMENTARY DNA; LUCIFERASE; MESSENGER RNA; TRANSCRIPTION FACTOR AP 2; TRANSCRIPTION FACTOR AP 2 ALPHA; UNCLASSIFIED DRUG; AURORA KINASE; PROTEASOME; PROTEIN SERINE THREONINE KINASE;

ARTICLE; CARCINOGENESIS; CELL CYCLE PROGRESSION; CENTROSOME; CONTROLLED STUDY; DOWN REGULATION; ENZYME ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME MECHANISM; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MOLECULAR DYNAMICS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; TRANSCRIPTION FACTOR AP 2 ALPHA GENE; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE; CELL CYCLE; CELL LINE; GENETIC TRANSCRIPTION; METABOLISM; PHYSIOLOGY; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL CYCLE; CELL LINE; DOWN-REGULATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION PROFILING; HUMANS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN-SERINE-THREONINE KINASES; TRANSCRIPTION FACTOR AP-2; TRANSCRIPTION, GENETIC;

EID: 79960943596     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0023110     Document Type: Article

References (44)

1. Giet R, Prigent C, (1999) Aurora/Ipl1p-related kinases, a new oncogenic family of mitotic serine-threonine kinases. J Cell Sci 112 (Pt21): 3591-3601.
2. Bischoff JR, Plowman GD, (1999) The Aurora/Ipl1p kinase family: regulators of chromosome segregation and cytokinesis. Trends Cell Biol 9: 454-459.
3. Fu J, Bian M, Jiang Q, Zhang C, (2007) Roles of Aurora kinases in mitosis and tumorigenesis. Mol Cancer Res 5: 1-10.
4. Bischoff JR, Anderson L, Zhu Y, Mossie K, Ng L, et al. (1998) A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers. EMBO J 17: 3052-3065.
5. Sen S, Zhou H, White RA, (1997) A putative serine/threonine kinase encoding gene BTAK on chromosome 20q13 is amplified and overexpressed in human breast cancer cell lines. Oncogene 14: 2195-2200.
6. Tong T, Zhong Y, Kong J, Dong L, Song Y, et al. (2004) Overexpression of Aurora-A contributes to malignant development of human esophageal squamous cell carcinoma. Clin Cancer Res 10: 7304-7310.
7. Wang XX, Liu R, Jin SQ, Fan FY, Zhan QM, (2006) Overexpression of Aurora-A kinase promotes tumor cell proliferation and inhibits apoptosis in esophageal squamous cell carcinoma cell line. Cell Res 16: 356-366.
8. Wajapeyee N, Somasundaram K, (2003) Cell cycle arrest and apoptosis induction by activator protein 2alpha (AP-2alpha) and the role of p53 and p21WAF1/CIP1 in AP-2alpha-mediated growth inhibition. J Biol Chem 278: 52093-52101.
9. Li Q, Dashwood RH, (2004) Activator protein 2alpha associates with adenomatous polyposis coli/beta-catenin and Inhibits beta-catenin/T-cell factor transcriptional activity in colorectal cancer cells. J Biol Chem 279: 45669-45675.
10. Friedrichs N, Jager R, Paggen E, Rudlowski C, Merkelbach-Bruse S, et al. (2005) Distinct spatial expression patterns of AP-2alpha and AP-2gamma in non-neoplastic human breast and breast cancer. Mod Pathol 18: 431-438.
11. Li H, Goswami PC, Domann FE, (2006) AP-2gamma induces p21 expression, arrests cell cycle, and inhibits the tumor growth of human carcinoma cells. Neoplasia 8: 568-577.
12. Wajapeyee N, Britto R, Ravishankar HM, Somasundaram K, (2006) Apoptosis induction by activator protein 2alpha involves transcriptional repression of Bcl-2. J Biol Chem 281: 16207-16219.
13. Williams T, Tjian R, (1991) Analysis of the DNA-binding and activation properties of the human transcription factor AP-2. Genes Dev 5: 670-682.
14. Douglas DB, Akiyama Y, Carraway H, Belinsky SA, Esteller M, et al. (2004) Hypermethylation of a small CpGuanine-rich region correlates with loss of activator protein-2alpha expression during progression of breast cancer. Cancer Res 64: 1611-1620.
15. Heimberger AB, McGary EC, Suki D, Ruiz M, Wang H, et al. (2005) Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas. Clin Cancer Res 11: 267-272.
16. Ruiz M, Pettaway C, Song R, Stoeltzing O, Ellis L, et al. (2004) Activator protein 2alpha inhibits tumorigenicity and represses vascular endothelial growth factor transcription in prostate cancer cells. Cancer Res 64: 631-638.
17. Tellez C, McCarty M, Ruiz M, Bar-Eli M, (2003) Loss of activator protein-2alpha results in overexpression of protease-activated receptor-1 and correlates with the malignant phenotype of human melanoma. J Biol Chem 278: 46632-46642.
18. Shao S, Wang Y, Jin S, Song Y, Wang X, et al. (2006) Gadd45a interacts with aurora-A and inhibits its kinase activity. J Biol Chem 281: 28943-28950.
19. Patterson TA, Lobenhofer EK, Fulmer-Smentek SB, Collins PJ, Chu TM, et al. (2006) Performance comparison of one-color and two-color platforms within the MicroArray Quality Control (MAQC) project. Nature biotechnology 24: 1140-1150.
20. Qiao JY, Shao W, Wei HJ, Sun YM, Zhao YC, et al. (2008) Novel high-throughput profiling of human transcription factors and its use for systematic pathway mapping. J Proteome Res 7: 2769-2779.
21. Shao W, Wei HJ, Qiao JY, Zhao YC, Sun YM, et al. (2005) Parallel profiling of active transcription factors using an oligonucleotide array-based transcription factor assay (OATFA). J Proteome Res 4: 1451-1456.
22. Wang Y, Yu J, Zhan Q, (2008) BRCA1 regulates caveolin-1 expression and inhibits cell invasiveness. Biochem Biophys Res Commun 370: 201-206.
23. Renard P, Ernest I, Houbion A, Art M, Le Calvez H, et al. (2001) Development of a sensitive multi-well colorimetric assay for active NFkappaB. Nucleic Acids Res 29: E21.
24. Aqeilan RI, Palamarchuk A, Weigel RJ, Herrero JJ, Pekarsky Y, et al. (2004) Physical and functional interactions between the Wwox tumor suppressor protein and the AP-2gamma transcription factor. Cancer Res 64: 8256-8261.
25. Fan W, Jin S, Tong T, Zhao H, Fan F, et al. (2002) BRCA1 regulates GADD45 through its interactions with the OCT-1 and CAAT motifs. Journal of biological chemistry 277: 8061.
26. Bosher JM, Totty NF, Hsuan JJ, Williams T, Hurst HC, (1996) A family of AP-2 proteins regulates c-erbB-2 expression in mammary carcinoma. Oncogene 13: 1701.
27. Orso F, Penna E, Cimino D, Astanina E, Maione F, et al. (2008) AP-2alpha and AP-2gamma regulate tumor progression via specific genetic programs. FASEB J 22: 2702-2714.
28. McPherson LA, Baichwal VR, Weigel RJ, (1997) Identification of ERF-1 as a member of the AP2 transcription factor family. Proceedings of the National Academy of Sciences of the United States of America 94: 4342.
29. Turner BC, Zhang J, Gumbs AA, Maher MG, Kaplan L, et al. (1998) Expression of AP-2 transcription factors in human breast cancer correlates with the regulation of multiple growth factor signalling pathways. Cancer research 58: 5466.
30. Leask A, Byrne C, Fuchs E, (1991) Transcription factor AP2 and its role in epidermal-specific gene expression. Proceedings of the National Academy of Sciences of the United States of America 88: 7948.
31. Katayama H, Sasai K, Kawai H, Yuan Z, Bondaruk J, et al. (2003) Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53. Nature genetics 36: 55-62.
32. Liu Q, Kaneko S, Yang L, Feldman RI, Nicosia SV, et al. (2004) Aurora-A abrogation of p53 DNA binding and transactivation activity by phosphorylation of serine 215. J Biol Chem 279: 52175-52182.
33. Li H, Watts GS, Oshiro MM, Futscher BW, Domann FE, (2006) AP-2alpha and AP-2gamma are transcriptional targets of p53 in human breast carcinoma cells. Oncogene 25: 5405-5415.
34. Hung L, Kannan P, (2006) Inefficient proteasomal-degradation pathway stabilizes AP-2alpha and activates HER-2/neu gene in breast cancer. International Journal of Cancer 118.
35. Littlepage L, Wu H, Andresson T, Deanehan J, Amundadottir L, et al. (2002) Identification of phosphorylated residues that affect the activity of the mitotic kinase Aurora-A. Proceedings of the National Academy of Sciences of the United States of America 99: 15440.
36. Qin L, Tong T, Song Y, Xue L, Fan F, et al. (2009) Aurora-A interacts with Cyclin B1 and enhances its stability. Cancer Lett 275: 77-85.
37. Ouchi M, Fujiuchi N, Sasai K, Katayama H, Minamishima Y, et al. (2004) BRCA1 phosphorylation by Aurora-A in the regulation of G2 to M transition. Journal of biological chemistry 279: 19643.
38. Sen S, Zhou H, Zhang RD, Yoon DS, Vakar-Lopez F, et al. (2002) Amplification/overexpression of a mitotic kinase gene in human bladder cancer. J Natl Cancer Inst 94: 1320-1329.
39. Brivanlou AH, Darnell JE Jr, (2002) Signal transduction and the control of gene expression. Science 295: 813-818.
40. Yang H, Ou CC, Feldman RI, Nicosia SV, Kruk PA, et al. (2004) Aurora-A kinase regulates telomerase activity through c-Myc in human ovarian and breast epithelial cells. Cancer research 64: 463.
41. García M, Campillos M, Marina A, Valdivieso F, Vázquez J, (1999) Transcription factor AP-2 activity is modulated by protein kinase A-mediated phosphorylation. FEBS letters 444: 27-31.
42. Hannak E, Kirkham M, Hyman AA, Oegema K, (2001) Aurora-A kinase is required for centrosome maturation in Caenorhabditis elegans. The Journal of cell biology 155: 1109.
43. Megraw TL, Li K, Kao LR, Kaufman TC, (1999) The centrosomin protein is required for centrosome assembly and function during cleavage in Drosophila. Development 126: 2829-2839.
44. Tsai MY, Wiese C, Cao K, Martin O, Donovan P, et al. (2003) A Ran signalling pathway mediated by the mitotic kinase Aurora A in spindle assembly. Nature cell biology 5: 242-248.